NCT04537455View on ClinicalTrials.gov

Non-invasive Mapping Using Ultra-high Frequency Electrocardiography

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 10, 2023

Study Completion Date

March 10, 2024

Conditions
Left Bundle-Branch BlockRight Bundle-Branch BlockNon-Specific Intraventricular Conduction Defect
Interventions
DIAGNOSTIC_TEST

Ultra-high frequency electrocardiography

Patients will have an ultra-high frequency electrocardiography performed.

Trial Locations (1)

W12 0HS

Hammersmith Hospital Imperial College NHS trust, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT04537455 - Non-invasive Mapping Using Ultra-high Frequency Electrocardiography | Biotech Hunter | Biotech Hunter